NC
RETA

NinePointTwo Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

NinePointTwo Capital’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,868
Closed -$292K – 340
2023
Q2 		$292K Buy
+2,868
New +$292K 0.11% 62
2022
Q1 		– Sell
-10,799
Closed -$284K – 257
2021
Q4 		$284K Buy
+10,799
New +$284K 0.09% 94